Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
22nd Century Group Inc. Common Stock is a drug manufacturers-specialty & generic business based in the US. 22nd Century Group IncCommon Stock shares (XXII) are listed on the NASDAQ and all prices are listed in US Dollars. 22nd Century Group IncCommon Stock employs 67 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $2.06 |
|---|---|
| 52-week range | $1.86 - $6.07 |
| 50-day moving average | $2.70 |
| 200-day moving average | $3.47 |
| Wall St. target price | $6.83 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.17 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.06 from 2022-01-21
| 1 week (2022-01-14) | -16.60% |
|---|---|
| 1 month (2021-12-19) | N/A |
| 3 months (2021-10-19) | N/A |
| 6 months (2021-07-23) | -34.81% |
| 1 year (2021-01-22) | -26.16% |
|---|---|
| 2 years (2020-01-23) | 92.52% |
| 3 years (2019-01-23) | 2.18 |
| 5 years (2017-01-23) | 125.14% |
| Revenue TTM | $30.3 million |
|---|---|
| Gross profit TTM | $1.4 million |
| Return on assets TTM | -21.98% |
| Return on equity TTM | -38.82% |
| Profit margin | -82.68% |
| Book value | $0.49 |
| Market capitalisation | $402 million |
TTM: trailing 12 months
We're not expecting 22nd Century Group IncCommon Stock to pay a dividend over the next 12 months.
22nd Century Group IncCommon Stock's shares were split on a 1391:500 basis on 29 November 2010. So if you had owned 500 shares the day before before the split, the next day you'd have owned 1391 shares. This wouldn't directly have changed the overall worth of your 22nd Century Group IncCommon Stock shares – just the quantity. However, indirectly, the new 64.1% lower share price could have impacted the market appetite for 22nd Century Group IncCommon Stock shares which in turn could have impacted 22nd Century Group IncCommon Stock's share price.
Over the last 12 months, 22nd Century Group IncCommon Stock's shares have ranged in value from as little as $1.86 up to $6.07. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 22nd Century Group IncCommon Stock's is 1.9169. This would suggest that 22nd Century Group IncCommon Stock's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
22nd Century Group, Inc. , a biotechnology company, develops plant-based solutions for the life science, consumer product, and pharmaceutical markets. It develops very low nicotine content tobacco and cigarette products under the Moonlight and Moonlight Menthol names; and SPECTRUM research cigarettes for use in independent clinical studies. 22nd Century Group, Inc. has collaboration with Keygene N. V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.